Abstract
Hepatic veno-occlusive disease (HVOD) after hematopoietic stem cell transplantation (HSCT) results in considerable morbidity and mortality. No therapy has been shown to be uniformly effective. Several studies have highlighted the pivotal role of endothelial injury and the hemostatic system in the pathogenesis of HVOD. Charcoal hemofiltration has been shown to be effective for adsorbing circulating bilirubin and other protein-bound toxins and for supporting patients in hepatic failure. We describe two adult patients with severe, biopsy-proven HVOD (peak bilirubin levels, more than 50 mg/dl in both cases) after HSCT who were successfully treated with charcoal hemofiltration after other treatments failed (including defibrotide in one patient). Both patients were heavily treated before they underwent either autologous (melphalan and total body irradiation conditioning) or allogeneic (cyclophosphamide and total body irradiation conditioning) HSCT. Additional studies are warranted to confirm this preliminary observation and investigate the mechanism of action. Bone Marrow Transplantation (2001) 28, 997–999.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McDonald GB, Sharma P, Matthews DE et al. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors Hepatology 1984 4: 116–122
Jones RJ, Lee KS, Beschorner WE et al. Venoocclusive disease of the liver following bone marrow transplantation Transplantation 1987 44: 778–783
Carreras E, Granena A, Rozman C . Hepatic veno-occlusive disease after bone marrow transplant Blood Rev 1993 7: 43–51
McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients Ann Intern Med 1993 118: 255–267
Bearman SI, Lee JL, Barón AE, McDonald GB . Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients Blood 1997 89: 1501–1506
Richardson PG, Elias AD, Krishnan A et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population Blood 1998 92: 737–744
Khoury H, Adkins D, Brown R et al. Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity? Bone Marrow Transplant 2000 25: 737–743
Ringden O, Remberger M, Lehmann S et al. N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation Bone Marrow Transplant 2000 25: 993–996
Bearman SI, Shen DD, Hinds MS et al. A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation Br J Haematol 1993 84: 724–730
Shulman HM, Gown AM, Nugent DJ . Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules Am J Pathol 1987 127: 549–558
Faioni EM, Mannucci PM . Venocclusive disease of the liver after bone marrow transplantation: the role of hemostasis Leuk Lymphoma 1997 25: 233–245
Vannucchi AM, Rafanelli D, Longo G et al. Early hemostatic alterations following bone marrow transplantation: a prospective study Haematologica 1994 79: 519–525
Harper PL, Jarvis J, Jennings I et al. Changes in the natural anticoagulants following bone marrow transplantation Bone Marrow Transplant 1990 5: 39–42
Testa S, Manna A, Porcellini A et al. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation Bone Marrow Transplant 1996 18: 383–388
Catani L, Gugliotta L, Vianelli N et al. Endothelium and bone marrow transplantation Bone Marrow Transplant 1996 17: 277–280
Davis DR, Yeary RA, Lee K . Activated charcoal decreases plasma bilirubin levels in the hyperbilirubinemic rat Pediatr Res 1983 17: 208–209
Ash SR, Blake DE, Carr DJ et al. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT) Int J Artif Org 1992 15: 151–161
Chen SC, Mullon C, Kahaku E et al. Treatment of severe liver failure with a bioartificial liver Ann NY Acad Sci 1997 831: 350–360
Ash SR, Blake DE, Carr DJ, Harker KD . Push–pull sorbent-based pheresis for treatment of acute hepatic failure: the BioLogic-detoxifier/plasma filter system Asaio J 1998 44: 129–139
Davis DR, Yeary RA . Activated charcoal as an adjunct to phototherapy for neonatal jaundice Dev Pharmacol Ther 1987 10: 12–20
O'Grady JG, Gimson AE, O'Brien CJ et al. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure Gastroenterology 1988 94: 1186–1192
Seda HW, Hughes RD, Gove CD, Williams R . Removal of inhibitors of brain Na+, K+-ATPase by hemoperfusion in fulminant hepatic failure Artif Org 1984 8: 174–178
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tefferi, A., Kumar, S., Wolf, R. et al. Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation. Bone Marrow Transplant 28, 997–999 (2001). https://doi.org/10.1038/sj.bmt.1703267
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703267
Keywords
This article is cited by
-
A Murine Model of Hepatic Veno-occlusive Disease Induced by Allogeneic Hematopoietic Stem Cell Transplantation
Cell Biochemistry and Biophysics (2013)
-
Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies
Bone Marrow Transplantation (2008)